Woodcock takes GMO to the next level

Share this article:
The FDA's director of drugs, Janet Woodcock, is pushing her manufacturing and product quality experts to “reinvigorate” her brainchild “GMPs (Good Manufacturing Practices) for 21st Century” initiative and move it to the next level.

“We've gotten a lot done on quality-by-design and our new review processes and so forth,” Woodcock said during a keynote address at an FDA/Temple University School of Pharmacy regulatory affairs conference.

“Industry is now stepping up to the plate, and we need to get to the next level, which would be to eliminate a lot of the manufacturing supplements because we have the appropriate quality-by-design information,” she said.

Last year at the Drug Information Association's annual meeting, FDA Office of New Drug Quality Assessment postmarketing evaluation division director Eric Duffy said the agency was developing categories of low-risk post-approval changes where less oversight might be appropriate. This effort was part of the agency's GMP initiative to develop a risk-based review paradigm to “downgrade” the filing categories for certain prior-approval supplements.

Also last year, the FDA held a public meeting on marketing application supplements where it received comments on how it could revise regulations to allow risk-based approaches based on manufacturing process understanding, and steps to reduce the number of supplements.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.